One such T2D comorbidity is hypothyroidism (HT), a metabolic disorder that dysregulates glucose and insulin homeostasis [7,8] which can exacerbate diabetic complications and thereby lead to poorer patient outcomes and increased care costs [7,9]. The gene discussed is INS; the disease is type 2 diabetes mellitus.